Recent Articles
- Pattern Bioscience Secures $28.7 Million in Series C Financing
- Pattern Bioscience Appoints Carey-Ann Burnham as Chief Clinical Officer
- Pattern Receives FDA “Breakthrough Device Designation” for Pneumonia Action Panel
- Building a Great Place to Work
- Pattern Raises Additional $9M to Fast-track New Technology for the Fight Against Antibiotic Resistance